Unknown

Dataset Information

0

Associations between hepatitis B virus mutations and the risk of hepatocellular carcinoma: a meta-analysis.


ABSTRACT: BACKGROUND: The association between hepatitis B virus (HBV) mutations and hepatocarcinogenesis remains controversial because of conflicting data in the literature. We conducted a meta-analysis of case-control and cohort studies to examine HBV PreS, enhancer II (EnhII), basal core promoter (BCP), and precore mutations in relation to the risk of hepatocellular carcinoma (HCC). METHODS: We searched databases for studies of these associations that were published in English or Chinese up to August 31, 2008. HBV mutation-specific odds ratios and relative risks were pooled by use of a random-effects model and stratified by potential confounders. All statistical tests were two-sided. RESULTS: Of the 43 studies included in this meta-analysis, 40 used a case-control design. The 43 studies evaluated a total of 11 582 HBV-infected participants, of whom 2801 had HCC. Statistically significant summary odds ratios of HCC were obtained for any PreS mutation (3.77, 95% confidence interval [CI] = 2.57 to 5.52), C1653T in EnhII (2.76, 95% CI = 2.09 to 3.64), T1753V (2.35, 95% CI = 1.63 to 3.40), and A1762T/G1764A in BCP (3.79, 95% CI = 2.71 to 5.29). PreS mutations were more strongly associated with an increased risk of HCC in subjects who were infected with HBV genotype C than in those who were infected with HBV genotype B, whereas the opposite was true for A1762T/G1764A. C1653T, T1753V, and A1762T/G1764A were more strongly associated with an increased risk of HCC in hepatitis B e antigen (HBeAg)-positive subjects than in HBeAg-negative subjects. PreS mutations, C1653T, T1753V, and A1762T/G1764A accumulated during the progression of chronic HBV infection from the asymptomatic carrier state to HCC (P(trend) < .001 for each mutation). PreS mutations, C1653T, C1653T + T1753V, and A1762T/G1764A-based combinations of mutations had specificities greater than 80% for the prediction of HCC. The precore mutations G1896A and C1858T were not associated with the risk of HCC, regardless of HBeAg status and HBV genotype. CONCLUSIONS: HBV PreS mutations, C1653T, T1753V, and A1762T/G1764A are associated with an increased risk of HCC. These mutations alone and in combination may be predictive for hepatocarcinogenesis.

SUBMITTER: Liu S 

PROVIDER: S-EPMC2720989 | biostudies-literature | 2009 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

Associations between hepatitis B virus mutations and the risk of hepatocellular carcinoma: a meta-analysis.

Liu Shijian S   Zhang Hongwei H   Gu Chunying C   Yin Jianhua J   He Yongchao Y   Xie Jiaxin J   Cao Guangwen G  

Journal of the National Cancer Institute 20090702 15


<h4>Background</h4>The association between hepatitis B virus (HBV) mutations and hepatocarcinogenesis remains controversial because of conflicting data in the literature. We conducted a meta-analysis of case-control and cohort studies to examine HBV PreS, enhancer II (EnhII), basal core promoter (BCP), and precore mutations in relation to the risk of hepatocellular carcinoma (HCC).<h4>Methods</h4>We searched databases for studies of these associations that were published in English or Chinese up  ...[more]

Similar Datasets

| S-EPMC3699046 | biostudies-literature
| S-EPMC8519208 | biostudies-literature
| S-EPMC7147033 | biostudies-literature
| S-EPMC7533945 | biostudies-literature
| S-EPMC6226104 | biostudies-literature
| S-EPMC4892830 | biostudies-literature
| S-EPMC4230159 | biostudies-literature
| S-EPMC3365888 | biostudies-literature
| S-EPMC3596299 | biostudies-literature
| S-EPMC3816781 | biostudies-literature